Mainz Biomed N.V (MYNZ) Debt to Equity: 2020-2024
Historic Debt to Equity for Mainz Biomed N.V (MYNZ) over the last 1 years, with Dec 2024 value amounting to $0.17.
- Mainz Biomed N.V's Debt to Equity fell 88.71% to $0.17 in Q4 2024 from the same period last year, while for Dec 2024 it was $0.17, marking a year-over-year decrease of 88.71%. This contributed to the annual value of $0.17 for FY2024, which is 88.71% down from last year.
- Mainz Biomed N.V's Debt to Equity amounted to $0.17 in Q4 2024, which was down 88.71% from $1.50 recorded in Q4 2023.
- Mainz Biomed N.V's 5-year Debt to Equity high stood at $2.01 for Q3 2023, and its period low was -$0.01 during Q4 2020.
- Over the past 3 years, Mainz Biomed N.V's median Debt to Equity value was $0.58 (recorded in 2023), while the average stood at $0.84.
- Its Debt to Equity has fluctuated over the past 5 years, first soared by 2,475.28% in 2021, then plummeted by 88.71% in 2024.
- Quarterly analysis of 5 years shows Mainz Biomed N.V's Debt to Equity stood at -$0.01 in 2020, then surged by 2,475.28% to $0.21 in 2021, then tumbled by 67.44% to $0.07 in 2022, then skyrocketed by 2,061.15% to $1.50 in 2023, then plummeted by 88.71% to $0.17 in 2024.
- Its Debt to Equity stands at $0.17 for Q4 2024, versus $1.50 for Q4 2023 and $2.01 for Q3 2023.